Weight loss drug giant Novo Nordisk collaborates with two companies on research on new therapies for cardiovascular metabolic diseases
bmxphg274
发表于 2024-1-5 11:07:12
1297
0
0
On January 4th, Danish pharmaceutical company Novo Nordisk announced a separate research collaboration with two American biotech companies, Omega Therapeutics and Cellerity, on new therapies for cardiovascular metabolic diseases.
It is reported that Novo Nordisk is collaborating with Omega to develop an epigenome controller using the company's platform technology, aimed at enhancing metabolism as part of a potential new approach to obesity management. The collaboration between this Danish pharmaceutical company and Cellerity will build upon previous work and utilize the company's platform to develop a small molecule therapy for the treatment of metabolic dysfunction related fatty hepatitis (MASH).
Novo Nordisk stated that these are the first two projects signed under the framework cooperation between Flagship Pioneering and Novo Nordisk. Flagship Pioneering is a biotechnology company dedicated to investing in platforms and creating companies that can change the world. (Huo Xingyu)
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- The 'darkest moment' of the 'seven giants' in the US stock market: $2 trillion market value evaporating, generative AI business difficult to make money
- US retail giant Target's US stock rose over 10% in pre-market trading
- Vaccine giant responds: nationwide suspension
- Iron ore giant, change of leadership
- After clocking in to work, I didn't come out again and was only discovered 4 days later! US trillion dollar banking giant, employee dies at workstation, police: investigating
- Cloud computing giant enters AI talent battle, acquires AI voice agency Tenyx
- The stock price has plummeted by 99% in the past three and a half years! American discount retail giant Bylottery files for bankruptcy
- Alibaba International Station has reached a cooperation agreement with global payment giant Mastercard
- Intel does not comment on the statement of "Qualcomm acquisition". Previous acquisitions between giants have been difficult due to antitrust scrutiny
- Tech giants jointly send letter to the European Union, can it knock on the door of EU regulation
-
热门中概股涨跌不一,纳斯达克中国金龙指数涨0.06%,本周累计上涨1.03%。蔚来涨超5%。
- sicklyman
- 5 小时前
- 支持
- 反对
- 回复
- 收藏
-
每经AI快讯,据亿航智能官微消息,公司EH216-S无人驾驶电动垂直起降航空器(eVTOL)获得巴西国家民航局颁发的试验飞行许可证书,并计划在巴西进行测试和试飞。关于EH216-S无人驾驶eVTOL在巴西的认证,中国民航局 ...
- 潇湘才子
- 昨天 08:41
- 支持
- 反对
- 回复
- 收藏
-
上证报中国证券网讯(记者俞立严)9月19日,蔚来全新品牌乐道的首款车型——乐道L60正式上市。新车定位家庭智能电动SUV,在采用BaaS电池租用服务后,L60的售价可低至14.99万元,电池租用月费最低为599元。乐道L6 ...
- anhao007
- 前天 11:03
- 支持
- 反对
- 回复
- 收藏
-
【博通或未在评估对英特尔发出收购要约】知情人士透露,博通目前没有在评估向英特尔发出收购要约。该公司曾评估过是否寻求交易,顾问在继续向博通提出建议。 ...
- jnengw
- 11 小时前
- 支持
- 反对
- 回复
- 收藏